Publications by authors named "Magdolna Tardy"

Claim this Profile
M
Maintenance treatment with antipsychotic drugs for schizophrenia.
Anna Ceraso, Jessie Jingxia Lin, Johannes Schneider-Thoma, Spyridon Siafis, Magdolna Tardy

Cochrane Database Syst Rev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials.
Markus Dold, Magdolna Tardy, Myrto T Samara, Chunbo Li, Siegfried Kasper

World J Biol Psychiatry· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Markus Dold, Myrto T Samara, Chunbo Li, Magdolna Tardy, Stefan Leucht

Cochrane Database Syst Rev· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
Magdolna Tardy, Maximilian Huhn, Rolf R Engel, Stefan Leucht

Cochrane Database Syst Rev· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Magdolna Tardy, Markus Dold, Rolf R Engel, Stefan Leucht

Cochrane Database Syst Rev· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
Magdolna Tardy, Maximilian Huhn, Rolf R Engel, Stefan Leucht

Cochrane Database Syst Rev· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
Magdolna Tardy, Markus Dold, Rolf R Engel, Stefan Leucht

Cochrane Database Syst Rev· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
Magdolna Tardy, Maximilian Huhn, Werner Kissling, Rolf R Engel, Stefan Leucht

Cochrane Database Syst Rev· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.
Maximilian Huhn, Magdolna Tardy, Loukia Maria Spineli, Werner Kissling, Hans Förstl

JAMA Psychiatry· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodiazepines for schizophrenia.
Markus Dold, Chunbo Li, Magdolna Tardy, Vesal Khorsand, Donna Gillies

Cochrane Database Syst Rev· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling

Lancet· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance treatment with antipsychotic drugs for schizophrenia.
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling

Cochrane Database Syst Rev· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis